Utama › Kanser Hati (Karsinoma Hepatoselular) › Oklahoma
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) di Oklahoma
5 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mencari peserta di lokasi di Oklahoma.
Bandar di Oklahoma
Teks kajian rasmi (Bahasa Inggeris)
The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 45 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06995898Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Oklahoma City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06921785A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- University of Oklahoma Health Sciences Center, Oklahoma City
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Apr 2026 · NCT05440708Combination of TATE and PD-1 Inhibitor in Liver Cancer
- University of Oklahoma Health Science Center, Oklahoma City
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03259867SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.